14.60
+0.32
(2.24%)
Jun 18 - Close
NYSE
real-time data -
Disclaimer
Currency in USD
| Range | 14.27 - 14.64 |
| 52 week | 11.68 - 16.08 |
| Open | 14.27 |
| Vol / Avg. | 0.00/38,606.00 |
| Mkt cap | 248.74M |
| P/E | 14.25 |
| Div/yield | - |
| EPS | 1.02 |
| Shares | 17.04M |
| Beta | 1.58 |
| Inst. own | 86% |
Events
Jun 7, 2013
Lydall Inc at Sidoti & Company Semi Microcap Conference
May 1, 2013
Q1 2013 Lydall Inc Earnings Conference Call
Apr 29, 2013
Q1 2013 Lydall Inc Earnings Release
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 4.54% | 4.44% |
| Operating margin | 6.58% | 5.64% |
| EBITD margin | - | 9.02% |
| Return on average assets | 7.05% | 6.90% |
| Return on average equity | 10.22% | 10.02% |
| Employees | 1,600 | - |
| Carbon Disclosure Rating | - | - |
Address
One Colonial Road
MANCHESTER, CT 06045-0151
United States - Map
+1-860-6461233 (Phone)
+1-860-6464917 (Fax)
MANCHESTER, CT 06045-0151
United States - Map
+1-860-6461233 (Phone)
+1-860-6464917 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Lydall, Inc. (Lydall), along with its subsidiaries, designs and manufactures specialty engineered filtration media, industrial thermal insulating solutions, automotive thermal and acoustical barriers, medical filtration media and devices and biopharmaceutical processing components for thermal/acoustical, filtration/separation and bio/medical applications. The Company operates in two segments: Performance Materials and Thermal/Acoustical. The Performance Materials segment reports the results of the Industrial Filtration, Industrial Thermal Insulation and Life Sciences Filtration businesses. The Thermal/Acoustical segment reports the results of Lydall�s automotive business, which includes Metal parts, Fiber parts and related Tooling. Other Products and Services (OPS) include Life Sciences Vital Fluids. In June 2011, it sold Lydall Industrial Thermal Solutions, Inc. On June 29, 2011, the Company sold its Affinity business.
Officers and directors
| W. Leslie Duffy Esq. | Independent Chairman of the Board | |
| Dale G. Barnhart | President, Chief Executive Officer, Director | |
| Robert K. Julian | Chief Financial Officer, Executive Vice President | |
| James V. Laughlan | Chief Accounting Officer, Controller, Treasurer | |
| Chad A. McDaniel | Vice President, General Counsel, Secretary | |
| Mona G. Estey | Vice President - Human Resources | |
| Kathleen Burdett | Independent Director | |
| Matthew T. Farrell | Independent Director | |
| Marc T. Giles | Independent Director | |
| William D. Gurley | Independent Director |